CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale Director sold 500,789 shares at an average $22.64 ($11,339,780)
- 4 Planned sale 10% owner sold 500,789 shares at an average $22.64 ($11,339,780)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 510,152 shares at an average $23.26 ($11,867,292)
- 4 Planned sale 10% owner sold 510,152 shares at an average $23.26 ($11,867,292)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 5,493 shares at $25.07 ($137,710)
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Gift CEO & President gave 21,500 shares (gift)
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 100 shares at $25.00 ($2,500)
- 4 Planned sale Chief Business Officer sold 20,000 shares at an average $24.53 ($490,510)
Page 25 of 40 · 796 filings